NDRA ENDRA Life Sciences
- 0.0799
- +0.0030+3.90%
- 0.0780
- -0.0019-2.38%
ENDRA Life Sciences News
DEFA14A: Others
8-K: Current report
DEF 14A: Definitive information statements
DEFA14A: Others
ARS: Annual Report to Security Holders
SC 13G: Statement of acquisition of beneficial ownership by individuals-S.H.N. Financial Investments Ltd.(9.99%)
SC 13G: Statement of acquisition of beneficial ownership by individuals-L1 Capital Global Opportunities Master Fund, Ltd.(9.99%)
PRE 14A: Preliminary proxy statements relating to merger or acquisition
8-K: Current report
424B3: Prospectus
EFFECT: Others
CORRESP: CORRESP
CORRESP: CORRESP
S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
8-K: Current report
10-Q: Quarterly report
8-K: ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update
S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
8-K: Current report
8-K: Current report
Analysis
Price Target
No Data
